Meta Platforms, Inc. - Class A Common Stock (NQ:META)
593.66
-13.04
(-2.15%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 20, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 21,323,945 |
| Open | 603.53 |
| Bid (Size) | 597.50 (120) |
| Ask (Size) | 597.89 (40) |
| Prev. Close | 606.70 |
| Today's Range | 587.25 - 603.96 |
| 52wk Range | 479.80 - 796.25 |
| Shares Outstanding | 2,877,000,000 |
| Dividend Yield | 0.35% |
Top News
More News
Performance
More News
Read More
What if ASML Becomes the Next Trillion-Dollar Stock? ↗
March 20, 2026
Broadcom Stock: Buy, Sell, or Hold? ↗
March 19, 2026
Frequently Asked Questions
Is Meta Platforms, Inc. - Class A Common Stock publicly traded?
Yes, Meta Platforms, Inc. - Class A Common Stock is publicly traded.
What exchange does Meta Platforms, Inc. - Class A Common Stock trade on?
Meta Platforms, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Meta Platforms, Inc. - Class A Common Stock?
The ticker symbol for Meta Platforms, Inc. - Class A Common Stock is META on the Nasdaq Stock Market
What is the current price of Meta Platforms, Inc. - Class A Common Stock?
The current price of Meta Platforms, Inc. - Class A Common Stock is 593.66
When was Meta Platforms, Inc. - Class A Common Stock last traded?
The last trade of Meta Platforms, Inc. - Class A Common Stock was at 03/20/26 04:00 PM ET
What is the market capitalization of Meta Platforms, Inc. - Class A Common Stock?
The market capitalization of Meta Platforms, Inc. - Class A Common Stock is 1,707.96B
How many shares of Meta Platforms, Inc. - Class A Common Stock are outstanding?
Meta Platforms, Inc. - Class A Common Stock has 1,708B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.